Todd ... hard to understand Amarin not grasping Rule 60 - they should pursue
But oddly shareholders taking this action may allow a different perspective to come into play - the District court has a new party to deal with - the shareholders who lost 7 billion in share value - not the company - it’s shareholders - you and me and thousands like us -because of Hikma and the way they ran the trial / expert evidence / documentary exhibits cropped and Mori being statistically incorrect
Rule 60 may be better presented by shareholders who suffered loss from this fraud on the court
But it is equally right they - Amarin-pursue ever other legal route available - cost is limitedrelative to other expenditures
It delays It’s wears down Hikma It make their risk reward uncertain in the extreme
It’s part of the reason Hikma has taken only small US market share
It dissuades other generics to pitch in
It buys Amarin time and preserves income
And winning taking any route would be ... incredible Alm
News 
Market Data 
Discover 
AI
